Unjha Formulations Intrinsic Value
Unjha Formulations (UNJHAFOR) median intrinsic value is ₹36.31 from 8 valuation models (range ₹12–₹53), vs current price ₹19.34 — +87.7% upside (Trading Below Calculated Value), margin of safety 46.7%. Browse UNJHAFOR balance sheet details for revenue, profit, balance sheet and cash flow data.
UNJHAFOR Valuation Methods Summary — DCF, Graham Number & P/E
Unjha Formulations intrinsic value across 8 models vs current price ₹19.34 — upside/downside and value range per method. Also explore Unjha Formulations share price performance to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹52.80 | ₹42.24 - ₹63.36 | +173.0% | EPS: ₹2.40, Sector P/E: 22x |
| Book Value Method | asset | ₹12.00 | ₹10.80 - ₹13.20 | -38.0% | Book Value/Share: ₹6.00, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹38.68 | ₹34.81 - ₹42.55 | +100.0% | Revenue/Share: ₹30.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹20.00 | ₹18.00 - ₹22.00 | +3.4% | EBITDA: ₹1.00Cr, EV/EBITDA: 10x |
| PEG Ratio Method | growth | ₹38.40 | ₹34.56 - ₹42.24 | +98.6% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹36.31 | ₹32.68 - ₹39.94 | +87.7% | Revenue Growth: 1.7%, Adj P/E: 15.1x |
| ROE Based Valuation | profitability | ₹32.00 | ₹28.80 - ₹35.20 | +65.5% | ROE: 33.3%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹12.00 | ₹10.80 - ₹13.20 | -38.0% | EPS: ₹2.40, BVPS: ₹6.00 |
UNJHAFOR Intrinsic Value vs Market Price — All Valuation Models
Unjha Formulations fair value range ₹12–₹53 vs current market price ₹19.34 across 8 valuation models. For current market price and key ratios, visit UNJHAFOR share price.
UNJHAFOR Intrinsic Value Analysis — Undervalued or Overvalued?
Unjha Formulations median intrinsic value ₹36.31, current price ₹19.34 — Trading Below Calculated Value by 87.7%, margin of safety 46.7%.
What is the intrinsic value of UNJHAFOR?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Unjha Formulations (UNJHAFOR) is ₹36.31 (median value). With the current market price of ₹19.34, this represents a +87.7% variance from our estimated fair value.
The valuation range spans from ₹12.00 to ₹52.80, indicating ₹12.00 - ₹52.80.
Is UNJHAFOR undervalued or overvalued?
Based on our multi-method analysis, Unjha Formulations (UNJHAFOR) appears to be trading below calculated value by approximately 87.7%.
UNJHAFOR Financial Health — Key Ratios vs Industry Benchmarks
Unjha Formulations financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 33.3% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 5.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 3.00x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
UNJHAFOR Cash Flow Quality — Operating & Free Cash Flow
Unjha Formulations operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |